Is Yumei Tablet an anti-inflammatory drug?

May 16, 2023 Source: Cainiu Health
Dr. Yang Shuwen
Introduction
Yumei Tablets belong to antitussive and expectorant drugs, and are a compound preparation. The main active ingredients are dextromethorphan hydrobromide and guaifenesin. After administration, the drug exerts its antitussive effect by suppressing the cough center in the brain. Its antitussive potency is equivalent to or slightly stronger than that of codeine, and it can be used to treat discomfort caused by upper respiratory tract infections and tracheitis.

Generally, Yumei tablets are not anti-inflammatory medications. The detailed explanation is as follows:

Yumei tablets belong to the category of antitussive and expectorant drugs. This compound medication primarily contains dextromethorphan hydrobromide and guaifenesin. After administration, it suppresses the cough center in the brain, thereby exerting a cough-suppressing effect. Its antitussive efficacy is equivalent to or slightly stronger than that of codeine, making it suitable for treating symptoms such as cough and sputum production caused by upper respiratory tract infections or tracheobronchitis. However, it generally does not possess anti-inflammatory properties. Patients may consult their doctor regarding the use of anti-inflammatory medications such as cefixime dispersible tablets or amoxicillin capsules for treatment.

When using Yumei tablets, patients must strictly follow medical advice and should not take the medication blindly. Possible adverse reactions during use include dizziness, belching, and loss of appetite; these side effects typically resolve spontaneously after discontinuation of the drug. Overdose may lead to serious adverse effects such as confusion, bronchospasm, or respiratory depression. The medication is not recommended for children under two years of age or women in the first trimester of pregnancy. If any discomfort occurs, patients are advised to seek prompt medical attention at a hospital.